These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6728894)

  • 1. [Enzymes as starting points for pharmaceutical development].
    Wagner G
    Pharmazie; 1984 Mar; 39(3):190-4. PubMed ID: 6728894
    [No Abstract]   [Full Text] [Related]  

  • 2. Thymidylate synthase inhibitors.
    Ismail AS; Grem JL
    Cancer Chemother Biol Response Modif; 2001; 19():1-19. PubMed ID: 11686010
    [No Abstract]   [Full Text] [Related]  

  • 3. Sequence-based identification of specific drug target regions in the thymidylate synthase enzyme family.
    Ferrari S; Losasso V; Costi MP
    ChemMedChem; 2008 Mar; 3(3):392-401. PubMed ID: 18270995
    [No Abstract]   [Full Text] [Related]  

  • 4. Prodrugs of thymidylate synthase inhibitors: potential for antibody directed enzyme prodrug therapy (ADEPT).
    Springer CJ; Bavetsias V; Jackman AL; Boyle FT; Marshall D; Pedley RB; Bisset GM
    Anticancer Drug Des; 1996 Dec; 11(8):625-36. PubMed ID: 9022750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future challenges in the clinical development of thymidylate synthase inhibitor compounds.
    Brandt DS; Chu E
    Oncol Res; 1997; 9(8):403-10. PubMed ID: 9436193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidyl biosynthesis enzymes as antibiotic targets.
    Chernyshev A; Fleischmann T; Kohen A
    Appl Microbiol Biotechnol; 2007 Feb; 74(2):282-9. PubMed ID: 17216455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The biochemical basis of pharmaceutical chemistry. 10. Enzymes and enzyme inhibitors as drugs].
    Nuhn P; Köhler T
    Pharmazie; 1991 May; 46(5):365-82. PubMed ID: 1896484
    [No Abstract]   [Full Text] [Related]  

  • 8. Thymidylate synthase inhibitors.
    Takimoto CH; Diggikar S
    Cancer Chemother Biol Response Modif; 2005; 22():1-18. PubMed ID: 16110605
    [No Abstract]   [Full Text] [Related]  

  • 9. Thymidylate synthase inhibitors as anticancer agents: from bench to bedside.
    Chu E; Callender MA; Farrell MP; Schmitz JC
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S80-9. PubMed ID: 12819937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Critical remarks on trimethoprim/sulfonamide combinations in veterinary medicine].
    Löscher W
    Dtsch Tierarztl Wochenschr; 1984 Apr; 91(4):135-9. PubMed ID: 6376046
    [No Abstract]   [Full Text] [Related]  

  • 11. Thymidylate synthase inhibitors.
    Touroutoglou N; Pazdur R
    Clin Cancer Res; 1996 Feb; 2(2):227-43. PubMed ID: 9816165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidylate synthase inhibitors.
    Ackland SP; Clarke SJ; Beale P; Peters GJ
    Cancer Chemother Biol Response Modif; 2002; 20():1-36. PubMed ID: 12703198
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: current status.
    Papamichael D
    Oncologist; 1999; 4(6):478-87. PubMed ID: 10631692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfamide antifolates inhibiting thymidylate synthase: synthesis, enzyme inhibition and cytotoxicity.
    Pawełczak K; Makowski M; Kempny M; Dzik JM; Gołos B; Rode W; Rzeszotarska B
    Acta Biochim Pol; 2002; 49(2):407-20. PubMed ID: 12362982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell death in response to antimetabolites directed at thymidylate synthase.
    Barbour KW; Berger FG
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):189-201. PubMed ID: 17396263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological and toxicological evaluation of a new series of thymidylate synthase inhibitors as anticancer agents.
    Benassi L; Magnoni C; Giudice S; Bertazzoni G; Costi MP; Rinaldi M; Venturelli A; Coppi A; Rossi T
    Anticancer Res; 2006; 26(5A):3499-504. PubMed ID: 17094473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidylate synthase inhibitors in colorectal cancer.
    Cassidy J
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):83-7. PubMed ID: 11049037
    [No Abstract]   [Full Text] [Related]  

  • 18. [Determination of the rate constants for the interaction of enzymes with substrates and inhibitors during a short incubation time].
    Brestkin AP; Maĭzel' EB
    Vopr Med Khim; 1975; 21(2):125-8. PubMed ID: 1138496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzoyl ring halogenated classical 2-amino-6-methyl-3,4-dihydro-4-oxo-5-substituted thiobenzoyl-7H-pyrrolo[2,3-d]pyrimidine antifolates as inhibitors of thymidylate synthase and as antitumor agents.
    Gangjee A; Jain HD; McGuire JJ; Kisliuk RL
    J Med Chem; 2004 Dec; 47(27):6730-9. PubMed ID: 15615522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of potent thymidylate synthase X inhibitors.
    Esra Onen F; Boum Y; Jacquement C; Spanedda MV; Jaber N; Scherman D; Myllykallio H; Herscovici J
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3628-31. PubMed ID: 18513963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.